New Mechanisms, New Measures in the Schizophrenia Treatment Landscape– Current challenges in the management of patients with schizophrenia are heightened by new quality measures, suboptimal adherence issues, and currently available therapeutic agents that address only positive symptoms. In this previously recorded interactive Web conference, a renowned expert in schizophrenia discusses contemporary treatment approaches and emerging therapeutic agents that extend beyond dopamine. Participants will also learn about updated HEDIS measures in schizophrenia. The educational format includes 3D animations and audience polling questions.
Examine the evidence in schizophrenia medication management.
Establish the impact of new HEDIS measures in schizophrenia treatment selection.
Evaluate the functionality and dysregulation of the glutamatergic neurochemical pathway pertaining to the pathophysiology of schizophrenia.
Differentiate mechanisms of action and potential value of glutamate system modulators in the treatment of schizophrenia.
1.0 Free CEUs for Nurses
This course also offers Free CEUs for Physicians and Pharmacists